Pain, Agitation/Sedation, Delirium, Immobility, Sleep Disruption, and Neuromuscular Blockade
Answer: D
This patient has a clear indication for intravenous pain
medication from his recent trauma and multiple frac-
tures. An βas-neededβ opiate would likely not keep up
with his pain control needs (Answers B and C are incor-
rect). His age and history of hypertension place him at
risk of delirium; therefore, a benzodiazepine is not the
best initial choice for this patient. A fentanyl infusion
for pain with a propofol infusion if needed for sedation
is the most appropriate answer (Answer A is incorrect;
Answer D is correct).
Chest tube removal is specifically cited in the PADIS
guidelines as an indication for both preemptive analge-
sia and nonpharmacologic relaxation techniques. This
is given a βstrongβ recommendation, determining that
the benefits outweigh the risks of preemptive therapy
(Answer D is correct). Acetaminophen given just before
the procedure will most likely not adequately treat pain
associated with chest tube removal (Answer A is incor-
rect). Increasing an opiate infusion several hours before a
bedside procedure can expose the patient to substantially
higher amounts of drug than needed and cause delayed
awakening times or other significant adverse effects
from opiates (Answer C is incorrect). Extensive stud-
ies of appropriate preemptive analgesia for chest tube
removal have not been completed; however, administer-
ing an opiate appropriately timed before manipulation of
a chest tube is an accepted standard of therapy (Answer
B is incorrect).
Answer: B
This patient has end-stage liver failure and acute renal
failure; he will therefore not predictably clear mid-
azolam or fentanyl infusions. With a RASS of β4 to β5,
indicating no meaningful responsiveness to stimuli, all
sedatives should be held if the patient is otherwise clini-
cally stable to allow time for clearance of medications. If
the patient was to develop pain based on a CPOT of 3 or
more, then intermittent fentanyl is appropriate (Answer
B is correct). A decrease in sedative dose or changing to
a different sedative is not needed at this time based on
the deeply sedated RASS score and would only further
delay awakening time. Intermittent doses of benzo-
diazepines should avoided. (Answers A, C, and D are
incorrect).
Answer: B
Withdrawal from certain home medications may occur
if these medications are not reinitiated within a few
days of admission. The onset of withdrawal symptoms
will vary depending on the half-life of each medication.
Symptoms may include agitation, anxiety, psychosis,
insomnia, hypertension, and tachycardia and can occur
with medications such as opiates, GABA receptor ago-
nists, antiepileptics, antidepressants, and antipsychotics.
A pharmacist can assist the medical team by obtaining
a thorough medication history and assessment of home
medication adherence to help identify drug withdrawal
symptoms. Reinitiating these medications can be con-
sidered, unless contraindicated because of the clinical
scenario (e.g., drug-drug interactions, drug-disease state
interactions). The Agitation and Sedation section of the
PADIS guidelines discusses identifying and treating
the etiology of agitation before adding other medica-
tions; reinitiating the benzodiazepine and antidepressant
to treat withdrawal symptoms is the most appropri-
ate answer (Answer B is correct). Neither fentanyl nor
dexmedetomidine would treat withdrawal from a ben-
zodiazepine or antidepressant (Answers A, C, and D are
incorrect).
Answer: C
The PADIS guidelines stress using nonpharmaco-
logic means to manage delirium when it is safe for the
patient. Strong evidence for using dexmedetomidine
to treat delirium is still not available and the MIND
USA Study has shown that anti-psychotics are ineffec-
tive at treating delirium. This patientβs presentation of
βalert and calm with intermittent periods of agitationβ
is a common scenario, and initial therapy should focus
on reorienting and getting the patient interactive and
mobile (Answers A and D are incorrect; Answer C is
correct). Dehydration is a common cause of agitation,
and it should be addressed; however, with normal lab-
oratory values and vital signs, this patient is unlikely
dehydrated at this time (Answer B is incorrect).
Answer: B
In the general population, systemic corticosteroids are
known to cause many neuropsychiatric events, includ-
ing hyperactivity and agitation; in a recent study of adult
ICU patients with acute lung injury, only age and use of
systemic corticosteroids in the preceding 24 hours were